These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15661530)

  • 1. p53: a heavily dictated dictator of life and death.
    Lu X
    Curr Opin Genet Dev; 2005 Feb; 15(1):27-33. PubMed ID: 15661530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription regulation by mutant p53.
    Weisz L; Oren M; Rotter V
    Oncogene; 2007 Apr; 26(15):2202-11. PubMed ID: 17401429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsp70 family member, mot-2/mthsp70/GRP75, binds to the cytoplasmic sequestration domain of the p53 protein.
    Wadhwa R; Yaguchi T; Hasan MK; Mitsui Y; Reddel RR; Kaul SC
    Exp Cell Res; 2002 Apr; 274(2):246-53. PubMed ID: 11900485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-specific mechanisms of p53 transcriptional control and prospects for cancer therapy.
    Resnick-Silverman L; Manfredi JJ
    J Cell Biochem; 2006 Oct; 99(3):679-89. PubMed ID: 16676359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 translational control: a new facet of p53 regulation and its implication for tumorigenesis and cancer therapeutics.
    Halaby MJ; Yang DQ
    Gene; 2007 Jun; 395(1-2):1-7. PubMed ID: 17395405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?
    Olsson A; Manzl C; Strasser A; Villunger A
    Cell Death Differ; 2007 Sep; 14(9):1561-75. PubMed ID: 17627286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of AIF expression by p53.
    Stambolsky P; Weisz L; Shats I; Klein Y; Goldfinger N; Oren M; Rotter V
    Cell Death Differ; 2006 Dec; 13(12):2140-9. PubMed ID: 16729031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
    Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
    Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
    Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
    Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of NFkappaB-responsive gene expression by DeltaNp73alpha in p53 null cells.
    Tanaka Y; Ota K; Kameoka M; Itaya A; Yoshihara K
    Exp Cell Res; 2006 May; 312(8):1254-64. PubMed ID: 16430884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of p53 expression in response to 5-fluorouracil in human cancer RKO cells.
    Ju J; Schmitz JC; Song B; Kudo K; Chu E
    Clin Cancer Res; 2007 Jul; 13(14):4245-51. PubMed ID: 17634554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wild-type p53 in cancer cells: when a guardian turns into a blackguard.
    Kim E; Giese A; Deppert W
    Biochem Pharmacol; 2009 Jan; 77(1):11-20. PubMed ID: 18812169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The etiology of human cancers.
    Kleihues P
    Prev Med; 1996; 25(1):13. PubMed ID: 8778752
    [No Abstract]   [Full Text] [Related]  

  • 14. Modifications of p53: competing for the lysines.
    Carter S; Vousden KH
    Curr Opin Genet Dev; 2009 Feb; 19(1):18-24. PubMed ID: 19179064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53: an overview of over two decades of study.
    Cheah PL; Looi LM
    Malays J Pathol; 2001 Jun; 23(1):9-16. PubMed ID: 16329542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable expression of temperature-sensitive p53: a suitable model to study wild-type p53 function in pancreatic carcinoma cells.
    Nuevemann D; Christgen M; Ungefroren H; Kalthoff H
    Oncol Rep; 2006 Sep; 16(3):575-9. PubMed ID: 16865258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting p53 tumor suppressor function in vivo through the analysis of genetically modified mice.
    Johnson TM; Attardi LD
    Cell Death Differ; 2006 Jun; 13(6):902-8. PubMed ID: 16557272
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.
    Baumbusch LO; Myhre S; Langerød A; Bergamaschi A; Geisler SB; Lønning PE; Deppert W; Dornreiter I; Børresen-Dale AL
    Mol Cancer; 2006 Oct; 5():47. PubMed ID: 17054774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of ANKRD11 as a p53 coactivator.
    Neilsen PM; Cheney KM; Li CW; Chen JD; Cawrse JE; Schulz RB; Powell JA; Kumar R; Callen DF
    J Cell Sci; 2008 Nov; 121(Pt 21):3541-52. PubMed ID: 18840648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 enters the microRNA world.
    Hermeking H
    Cancer Cell; 2007 Nov; 12(5):414-8. PubMed ID: 17996645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.